Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: HIGHLY RECOMMENDED READING

Makes one wonder why they've been settling for 0.001%, or thereabouts, with the early movers. As I have always argued, licensing should reflect the market average.

It can only be hoped that ALL future licenses are not given away.

 

 

Be well

Share
New Message
Please login to post a reply